NIHON SHOKUHIN KAKO Resident Skin Flora Improving Agent
Summary
USPTO published patent application US20260108447A1 for a resident-skin-flora-improving agent using sophorose, filed by NIHON SHOKUHIN KAKO CO., LTD. on October 2, 2023. The application discloses that sophorose promotes proliferation of beneficial skin bacteria while suppressing growth of bacteria that could adversely affect the skin, and can be used to maintain balance of resident skin flora.
“There is provided a resident-skin-flora-improving agent that is useful in keeping the skin in excellent condition.”
About this source
GovPing monitors USPTO Patent Applications - Therapeutics (A61P) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 219 changes logged to date.
What changed
USPTO published patent application US20260108447A1 filed by NIHON SHOKUHIN KAKO CO., LTD. on October 2, 2023, for a resident-skin-flora-improving agent and external-use composition for skin. The application claims the use of sophorose as an active ingredient that promotes proliferation of beneficial bacteria while suppressing harmful bacteria on the skin.
Parties interested in skincare formulations, cosmetics manufacturing, or microbiome-based product development should review this published application to assess potential freedom-to-operate considerations or licensing opportunities.
Archived snapshot
Apr 23, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
RESIDENT-SKIN-FLORA-IMPROVING AGENT AND EXTERNAL-USE COMPOSITION FOR SKIN
Application US20260108447A1 Kind: A1 Apr 23, 2026
Assignee
NIHON SHOKUHIN KAKO CO., LTD.
Inventors
Moeko AIZAWA, Kenji YAMANE
Abstract
There is provided a resident-skin-flora-improving agent that is useful in keeping the skin in excellent condition. Specifically, there is provided a resident-skin-flora-improving agent in which sophorose is used. Sophorose is provided with functionality by which it is possible to promote proliferation of helpful bacteria that beneficially affect skin while suppressing growth of bacteria that could adversely affect the skin. The resident-skin-flora-improving agent can suitably be used for the object of maintaining balance of the resident skin flora and keeping the skin in excellent condition.
CPC Classifications
A61K 8/60 A61K 31/7016 A61P 17/00 A61Q 19/00 A61K 2800/74 A61Q 5/02 A61Q 19/007
Filing Date
2023-10-02
Application No.
19117294
Parties
Related changes
Get daily alerts for USPTO Patent Applications - Therapeutics (A61P)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Therapeutics (A61P) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.